Location History:
- Seoul, KR (2019 - 2022)
- Daejeon, KR (2024)
Company Filing History:
Years Active: 2019-2024
Title: Byoung Chul Cho: Innovator in Cancer Treatment
Introduction
Byoung Chul Cho is a prominent inventor based in Seoul, South Korea. He has made significant contributions to the field of pharmaceuticals, particularly in the development of innovative compounds for cancer treatment. With a total of 4 patents to his name, Cho's work focuses on creating effective solutions for combating cancer.
Latest Patents
Cho's latest patents include an isoindolin-1-on derivative, which is designed to prevent or treat cancer. This invention highlights a method for preparing the derivative and a pharmaceutical composition that utilizes it as an effective component. The isoindolin-1-on derivative demonstrates a high inhibitory effect on EGFR mutations, making it a valuable asset in treating EGFR-mutated tumors. Additionally, it exhibits significant synergistic effects when co-administered, enhancing its therapeutic potential.
Another notable patent is the N2,N4-diphenylpyrimidine-2,4-diamine derivative. This invention also includes a method for preparation and a pharmaceutical composition for cancer prevention or treatment. The derivative shows a relatively weak inhibitory effect on wild-type EGFR but possesses a high inhibitory ability on EGFR mutations and FLT3 mutations. This makes it particularly effective for treating cancers associated with these mutations, especially when used in combination therapies.
Career Highlights
Throughout his career, Byoung Chul Cho has worked with esteemed institutions such as the Korea Research Institute of Chemical Technology and Yonsei University. His research and innovations have significantly advanced the understanding and treatment of cancer.
Collaborations
Cho has collaborated with notable colleagues, including Kwangho Lee and Gildon Choi. These partnerships have contributed to the success of his research and the development of his patented inventions.
Conclusion
Byoung Chul Cho is a dedicated inventor whose work in cancer treatment showcases his innovative spirit and commitment to improving healthcare. His patents reflect a deep understanding of pharmaceutical chemistry and a desire to make a meaningful impact in the fight against cancer.